Letters to the Editor

Incidence and outcomes of treatment-associated hepatotoxicity during pediatric acute lymphoblastic leukemia induction therapy: a Reducing Ethnic Disparities in Acute Leukemia (REDIAL) Consortium report

Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, TX
Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, TX, USA; Texas Children’s Cancer and Hematology Centers, Houston TX
Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, TX, USA; Texas Children’s Cancer and Hematology Centers, Houston TX
Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, TX, USA; Texas Children’s Cancer and Hematology Centers, Houston TX
Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, TX, USA; Texas Children’s Cancer and Hematology Centers, Houston TX
Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, TX, USA; Texas Children’s Cancer and Hematology Centers, Houston TX
University of Texas Southwestern Medical Center, Peter O’Donnell Jr. School of Public Health, Dallas, TX, USA; Harold C. Simmons Comprehensive Cancer Center, Dallas, TX
St. Jude Children’s Research Hospital, Department of Pharmacy and Pharmaceutical Sciences, Memphis, TN
University of Texas Southwestern Medical Center, Department of Pediatrics, Dallas, TX
Harold C. Simmons Comprehensive Cancer Center, Dallas, TX, USA; University of Texas Southwestern Medical Center, Department of Pediatrics, Dallas, TX
Cook Children's Medical Center, Department of Hematology/Oncology, Fort Worth, TX
Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, TX, USA; Texas Children’s Cancer and Hematology Centers, Houston TX
Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, TX
Vannie E. Cook Children Cancer and Hematology Clinics, McAllen, TX
Vannie E. Cook Children Cancer and Hematology Clinics, McAllen, TX
University of Virginia School of Medicine, Division of Biostatistics, Charlottesville, VA
Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, TX, USA; Texas Children’s Cancer and Hematology Centers, Houston TX
Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, TX, USA; Texas Children’s Cancer and Hematology Centers, Houston TX
Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, TX, USA; Texas Children’s Cancer and Hematology Centers, Houston TX
University of California, Los Angeles, David Geffen School of Medicine, Division of Pediatric Endocrinology, Los Angeles, CA
Children’s Hospital of Orange County, University of California Irvine College of Medicine, Orange, CA
Children’s Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, CA
Baylor College of Medicine, Department of Pediatrics, Division of Hematology/Oncology, Houston, TX, USA; Texas Children’s Cancer and Hematology Centers, Houston TX
Haematologica Early view Jan 22, 2026 https://doi.org/10.3324/haematol.2025.288274